Gilead Sciences (GILD) Stock: Revenue, Earnings, Margins & Valuation
Gilead Sciences share price
| Price (USD) | 170.68 |
|---|---|
| Price date | 2026-10-31 |
| Market capitalization | 211.64 USD bn |
Annual and quarterly filings: SEC EDGAR – Gilead Sciences
Gilead Sciences (GILD), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report, visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Gilead Sciences business model
The income statement of Gilead Sciences is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
Sector: Health Care
More stock analyses like Gilead Sciences
- HCA Healthcare stock (HCA)
- Henry Schein stock (HSIC)
- Humana stock (HUM)
- Idexx Laboratories stock (IDXX)
- Global Payments stock (GPN)
- Genuine Parts Company stock (GPC)
- Globe Life stock (GL)
- General Motors stock (GM)